9th Annual Pharma Regulatory Summit - 2026
Upcoming9th Annual Pharma Regulatory Summit - 2026
- Dates: 24 Mar 2026 — 24 Mar 2026
- 0.00
About the Event
Virtue Insight was founded in 2009. We equip business professionals around the world with the latest in-depth industry knowledge and provide networking opportunities in telecom, technology and pharmaceutical industries. Our aim is to provide a platform to share knowledge, insight and provide our clients to network effectively and deliver maximum ROl by making new business alliances. We strive to produce high quality conferences that include the latest topics which are delivered by world class leaders of the industry. We are based out in India, USA and UK
Event Highlights
We believe in gathering information from all possible sources and try to be at top as possible. Our clients trust us on being capable of "staying ahead" with this competitive market .As we grow very fast with new opportunities, we welcome our new team members on regular intervals and provide them with lots of opportunities to expand their horizon.As the technology is taking a vast space, we provide assistance with new ideas and thoughts to our stakeholders. We work with the lastest technology with updated and empowered thought process.We believe in providing the best comfort by understanding the client's need through our friendly culture. We have a win-win relationship with all our customers in place.
Contact Information
Contact Person
Email Address
Phone Number
Alternate Phone
Exhibitor Portal
Join our network of exhibitors and showcase your services to millions of travelers.
Event Speakers
AKSHAYA ODAK
Head Regulatory Affairs (Biotech) at Lupin
AMARNATH SUGUMARAN
Director - Medical Affairs at Cipla
AMITA BHAVE
Director Regulatory Affairs at AstraZeneca
AMOL CHOULWAR
Group Leader - Regulatory Affairs at (Biosimilar Peptides New Drugs Vaccines), Cipla
ANJU AGARWAL
Director Global Patient Safety Advanz Pharma
DISHA DHAIRYAWAN
Regulatory Affairs, at CHC India
JAYASHRI PRAMOD
Regulatory Principal Specialist at Novo Nordisk
JULIET REBELLO
Director - Clinical Dev Strategy & Medical Writing, at Cipla
KAVITA LAMROR
Partner, RWE & Digital Transformation at Maxis Clinical Sciences
MANASA KASIVAJJULA
CEO and Co-Founder at DeepForrest.ai (A CtrlS Company)
MAYUR PARMAR
Drugs Inspector (Deputy Collector, Gujarat Government), at FDA
MILIND ANTANI
Leader, Pharma & Healthcare at Nishith Desai Associates
MINOO BIJU
Head-Regulatory Affairs at Piramal Pharma Solutions
MITUL CHATTERJEE
Director Regulatory Affairs at Baxter Pharmaceuticals
NAGENDRAN IRUKULAPATI
Sr. Vice President – Global Regulatory Affairs, Aurobindo Pharma at Aurobindo Pharma
NEELU GOEL
Regulatory Affairs - Head Business at Continuity & Compliance, Sun Pharma
OMPRAKASH S. SADHWANI
Former Joint Commissioner & Controlling Authority at FDA (Maharashtra State)
PALLAVI TRIVEDI
Associate Director – Diabeties and Obesity, at Global Business Services (GBS)Novo Nordisk
PANKAJ CHAUDHARI
Head - Global Regulatory Affairs at (Biosimilar), Abbott
PANKAJ THAKUR
Sr GM & Head Project Management at Hetero Labs
PRIYA CHATTERJEE
Head Regulatory Affairs - South Asia at Bayer
PRIYA PRASAD
General Manager – PV at Lupin
PROTITI BAGCHI
Associate Director- Digital Transformation at GSK
RAMANARAYANA PARHI
Vice President & CIO Alkem Laboratories at Vice President & CIO Alkem Laboratories
RASHMI HEGDE
Former Executive Vice President – at Medical,
SAKSHI SHRIVASTAVA DESAI
Director, LMS regional Lead APAC at Johnson & Johnson Innovative Medicine
SAMIR SHAH
Sr. General Manager, Head, at Regulatory Affairs (API), Zydus Lifesciences
Sanofi SADANAND KULKARNI
Head - Medical, Regulatory, Vigilance & Quality (South Asia), at Fresenius Kabi
SANTOSH TAUR
Director Medical Affairs, Vaccines, Rare Diseases and Digital at Pfizer
SHIRAZ KANDAWALLA
Head – Regulatory, Quality & Safety – India, at Ferring Pharma
SHUVANKAR BALLAV
Head, Regulatory Affairs - Advanced at Biotech Lab (ABL), Ipca Laboratories
SUCHITA MORE
Director Medical Modernization, Asia at Asia
SUSHMITA KUSWA
Head Medical & Regulatory Affairs at Piramal
Customer Reviews
Please log in to leave a review
Login to ReviewWhat People Are Saying
No reviews yet
Be the first to share your experience!
Coffee and Registration
Tuesday, 24 Mar 2026Coffee and Registration
Coffee and Registration
Welcome Address & Opening Remarks
Welcome Address & Opening Remarks
Regulatory Roadmap for Generics:
Compliance Strategies for a Competitive Market Global regulatory updates shaping new drug development Early regulatory engagement and scientific advice pathways Streamlined clinical development and accelerated approval routes Ensuring safety, immunogenicity, and quality standards Strengthening CMC and manufacturing compliance Global health priorities and pandemic-readiness frameworks End-to-end patient safety and post-market surveillance
| Time | Type | Title | Speaker(s) | Venue / Room | Notes |
|---|---|---|---|---|---|
|
8:30 AM 9:00 AM |
Opening Ceremony | Coffee and Registration | – | – | Coffee and Registration |
|
9:20 AM 10:00 AM |
Opening Ceremony | Welcome Address & Opening Remarks | – | – | Welcome Address & Opening Remarks |
|
9:30 AM 10:00 AM |
Session | Regulatory Roadmap for Generics: | – | – | Compliance Strategies for a Competitive Market Global regulatory updates shaping new drug development Early regulatory engagement and scientific advice pathways Streamlined clinical development and accelerated approval routes Ensuring safety, immunogenicity, and quality standards Strengthening CMC and manufacturing compliance Global health priorities and pandemic-readiness frameworks End-to-end patient safety and post-market surveillance |
Event Details
-
Event Dates 24 Mar 2026 — 24 Mar 2026
-
Location Hotel Kohinoor Continental, Mumbai, Maharashtra, India
-
Venue Hotel Kohinoor Continental
-
Event Type Summit
-
Entry Fees Free
-
Frequency 2
-
Timings 10 AM To 6 PM
-
Pincode 400059
Participate
How would you participate in the Event ?